Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 589 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SIGNAL Clear all

Conditions: Neck Pain, Cervicalgia, Facet Joint Pain
Interventions: Intra-articular cervical zygapophyseal joint injection; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Palo Alto, California • Redwood City, California • Nashville, Tennessee

Conditions: PIK3CA Mutations, Advanced Solid Tumors, Adult, Endometrial Cancer, HR Positive/HER-2 Negative Breast Cancer, HER2-low Breast Cancer
Interventions: CGT6297; Drug
Lead sponsor: Cogent Biosciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 12
States / cities: Scottsdale, Arizona • Los Angeles, California • Palo Alto, California + 9 more

Conditions: Hearing Loss, Sensorineural, Hearing Loss, Hearing Loss, Bilateral
Interventions: Electrocochleography; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 79 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 5
States / cities: Rochester, Minnesota • St Louis, Missouri • Chapel Hill, North Carolina + 2 more

Conditions: Thyroid Nodule
Interventions: Contrast-enhanced ultrasound, Shear Wave Elastography, Sequoia System; Other · Device
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer Female
Interventions: Bupivacaine Hydrochloride, Placebo Drug, Pulsed Electromagnetic Field (PEMF) Device, Placebo Device, Ropivacaine Hydrochloride; Drug · Other · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Surgery, Bispectral Index
Interventions: BIS sensor; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Traumatic Brain Injury
Interventions: Motek C-Mill™ treadmill, training session with and without VR wearing the fNIRS cap; Device · Other
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Acute Rejection (AR) of Transplanted Kidney, Chronic Allograft Nephropathy (CAN), Interstitial Fibrosis (IF), Tubular Atrophy (TA)
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Peripheral Arterial Disease, Critical Limb Ischemia
Interventions: BOLD-MRI; Other
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 19 Years to 89 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Springfield, Illinois

Conditions: Cortical Excitability, Psychiatric Disorder
Interventions: L-theanine, Placebo; Drug
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Atopic Keratoconjunctivitis
Interventions: Cyclosporin 0.05% ophthalmic; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Uterine Cancer, Cervical Cancer, Gynecologic Cancer
Interventions: SIGNAL; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Neural Tube Defects, Folic Acid Deficiency, Fortification
Interventions: Salt with folic acid and iodine; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Cranial Neurosurgery
Interventions: Medtronic LINQII; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Overactive Bladder
Interventions: Tibial nerve stimulation; Device
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Torrance, California

Conditions: Parkinson, Parkinson Disease
Interventions: Neuroimaging, Quantitative assessments; Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years to 75 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Traumatic Brain Injury, Post-concussive Syndrome
Interventions: Sildenafil; Drug
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Benign, Malignant Neoplasm of Breast, Breast Malignant Tumor
Interventions: Magnetic Resonance Imaging (MRI); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 20 Years to 80 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Focus is on Healthy Subjects
Interventions: measure ascending aortic blood flow with pulse wave Doppler; Device
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Suicidal Ideation, Suicidal and Self-injurious Behavior, Suicide, Autism Spectrum Disorder
Interventions: Safety Planning Intervention tailored for Autistic Individuals, Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up Contacts; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 12 Years to 99 Years
Enrollment: 1,665 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 5
States / cities: Baltimore, Maryland • Chapel Hill, North Carolina • Columbus, Ohio + 2 more

Conditions: Type 1 Diabetes
Interventions: Bi-homonal Bionic Pancreas, Usual care; Device · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hearing, Hearing Loss
Interventions: Speech Manipulation; Behavioral
Lead sponsor: Marquette University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 680 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Milwaukee, Wisconsin

Conditions: Intracranial Hemorrhages, Traumatic Brain Injury
Interventions: SENSE Device; Device
Lead sponsor: Sense Diagnostics, LLC; Industry
Eligibility: 22 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer, ERBB2 Gene Amplification, HER2 Overexpression, Non-Small Cell Lung Cancer, HER2
Interventions: CGT4255; Drug
Lead sponsor: Cogent Biosciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 15
States / cities: Scottsdale, Arizona • New Haven, Connecticut • Jacksonville, Florida + 11 more

Search by objective public record fields.

Cortisone Shots for Neck Pain

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Utility of Contrast-Enhanced Sonography and Shear Wave Elastography

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Bispectral Index: A Comparison of Bifrontal Montage Agreement

Functional Near-Infrared Spectroscopy (fNIRS) Assessing Neural Activity During Virtual Reality Walking Intervention

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI

Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS Study

Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis

SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care

Feasibility, Acceptability and Directional Signal Effect on Blood Folate Levels of Iodized Salt Fortified With Folic Acid: Clinical Study

A Study Of Subscalp Placement Of The LINQII Device

TTNS vs PTNS in a County Hospital System.

Neuroplasticity in Parkinson's Disease

Sildenafil for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury.

Low-field MRI for Breast Cancer Screening

Validation of Pulse Wave Doppler Demodulation Algorithm for the Continuous, Non-invasive Measurement of Blood Flow Velocity

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas

Perception of Speech in Context by Listeners With Healthy and Impaired Hearing

Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial Hemorrhage

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors